In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
In simple terms, retinoblastoma is an eye cancer that develops in the immature cells of the retina. Though it is rare—with approximately 300 children diagnosed in the U.S. each year—it is the most common eye cancer in children. This malignant intraocular cancer rarely occurs in adults. Retinoblastoma can occur in one or both eyes and is caused by genetic mutations in the nerve cells of the retina. The retina is comprised of nerve tissue and is the part of the eye that’s responsible for sensing...
Wilms tumor is a type of kidney cancer that primarily develops in children around the ages of three and four. It’s the most common type of kidney cancer found in kids. Approximately 9 out of 10 kidney cancers in children are Wilms tumors, sometimes known as nephroblastoma. There are two types of Wilms tumors that are classified by their histology, or how they look microscopically: favorable histology and anaplastic histology. A Wilms tumor with favorable histology means that, while the tumor...
Childhood cancer is a big problem. In the U.S. alone, 46 children are diagnosed with cancer every school day. But it doesn’t just affect school-age children -- babies, teens, and young adults can get childhood cancer, too. In the last 20 years, thanks to research, many more young children and older adults are surviving their cancers. But that’s not the case for teens and young adults. Teens and young adults are unique. Their cancers are different, their bodies are different, and they face...
Acute myeloid leukemia (AML) is a blood cancer of the myeloid cells that normally form white blood cells, red blood cells or platelets. AML originates in the bone marrow, where the leukemia cells build up and overcrowd normal cells. The leukemia cells often move into the bloodstream fairly quickly. AML is the second most common form of childhood leukemia, after acute lymphoblastic leukemia (ALL). AML is much more common in adults versus children; the average age of diagnosis is 68. There are...
Breakthroughs happen — in science, in medicine and especially in childhood cancer research — with outside-the-box thinking. At Rally Foundation, we believe that bold ideas deserve a chance, and each one may be that next big breakthrough. That’s why we created the Outside the Box Grant. We want to fund innovative, early-stage research to challenge the status quo and inspire new discoveries. Each year, the focus of this grant shifts to meet emerging needs in childhood cancer research. For 2025,...
At Rally, we believe that innovative research begins with innovative researchers. That’s why we are thrilled to announce the recipients of our Rally Career Development Awards, an investment of $1,250,000 in the future of childhood cancer research. So, what is a Rally Career Development Award? This award targets early-career investigators. In their first independent faculty appointment, they are transitioning from mentorship to launching their own research labs, publishing their own findings...